What if the cure for cancer starts in orbit? 🌌

In this presentation, the speaker argues that the key to curing cancer lies in space. Citing 2022 statistics that over 10 million people died from cancer—including two of the speaker’s aunts—the talk highlights the massive failure rate of oncology drugs, with 90 % failing to reach market due to inaccurate preclinical selection and severe side effects. The speaker references three decades of International Space Station research showing that cancer cells grow up to 100 times faster in microgravity, making space an ideal environment to test the most aggressive tumors quickly. By using this accelerated growth, Exobiosphere’s platform aims to screen drug candidates far faster than Earth‑based methods, promising stronger, safer therapies, billions of dollars in cost savings, and millions of lives saved.










